ADVANCED CANCER
Clinical trials for ADVANCED CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CANCER trials appear
Sign up with your email to follow new studies for ADVANCED CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bile duct cancer: maintenance therapy trial launches
Disease control Not yet recruitingThis study is for people with advanced biliary tract cancer whose disease is stable after initial chemotherapy and immunotherapy. It tests whether adding different drugs (lenvatinib, venadaparib, or IL-2) to maintenance immunotherapy can keep the cancer under control longer. Abou…
Matched conditions: ADVANCED CANCER
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
New triple therapy shows promise in stomach cancer fight
Disease control Not yet recruitingThis study tests whether adding the experimental drug TST001 to standard chemotherapy and immunotherapy can help people with advanced stomach or gastroesophageal junction cancer live longer without their disease getting worse. About 820 adults with a specific tumor marker (Claudi…
Matched conditions: ADVANCED CANCER
Phase: PHASE3 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New hope for advanced myeloma: pfizer launches early trial
Disease control Not yet recruitingThis early-phase study tests a new drug, PF-07994525, in 120 adults with advanced multiple myeloma that has returned or not responded to treatment. The goal is to find a safe dose and see if the drug can shrink tumors. Researchers will closely monitor side effects and how the bod…
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
New cancer pill TQB3217 enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests a new tablet called TQB3217 in 40 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. This is a first-in-human trial, s…
Matched conditions: ADVANCED CANCER
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Can talking about death help caregivers cope? new study aims to find out.
Symptom relief Not yet recruitingThis study tests whether a four-session death education program can help family caregivers of advanced cancer patients feel less anxious, depressed, and more at peace. About 30 caregivers will take part in one-on-one sessions over four weeks. The main goal is to see if the progra…
Matched conditions: ADVANCED CANCER
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated May 26, 2026 03:19 UTC
-
Can spiritual care ease the burden of advanced cancer?
Symptom relief Not yet recruitingThis study looks at whether two types of spiritual care can help people with advanced cancer feel better spiritually and use healthcare services differently. About 288 patients from religious communities will take part. Researchers will measure spiritual well-being, quality of li…
Matched conditions: ADVANCED CANCER
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated May 26, 2026 03:13 UTC
-
New program aims to ease tough End-of-Life talks for cancer patients
Symptom relief Not yet recruitingThis study tests a program called ROCKS to help people with advanced cancer and their family caregivers talk about and plan for future medical care. About 152 patient-caregiver pairs will be randomly assigned to the program or usual care. The goal is to see if the program helps m…
Matched conditions: ADVANCED CANCER
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated May 26, 2026 03:12 UTC
-
New app aims to ease cancer pain management
Symptom relief Not yet recruitingThis study tests a smartphone app called I-STAMP designed to help people with advanced cancer manage their pain and keep track of their medications. About 73 participants will use the app and then rate how easy it is to use and how helpful they find it. The goal is to see if the …
Matched conditions: ADVANCED CANCER
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 26, 2026 03:08 UTC
-
New Cement-and-Sound combo aims to calm cancer bone pain
Symptom relief Not yet recruitingThis study tests whether a special bone cement (made with bioactive glass) combined with ultrasound can safely stabilize bones and reduce pain in people with advanced cancer that has spread to the pelvis. Only 8 participants will receive the treatment alongside standard care, and…
Matched conditions: ADVANCED CANCER
Phase: NA • Sponsor: Liao Yun • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC